How does peripheral lipopolysaccharide induce gene expression in the brain of rats?

Ashok K Singh, Yin Jiang

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

Lipopolysaccharide (LPS), the principal cell-wall component of gram-negative bacteria, is responsible for alterations in the central and peripheral tissues associated with gram-negative infections. However, the mechanism by which peripheral LPS cause central effects is not fully known. This study showed that peripheral LPS sequentially increased IL-1β and iNOS mRNA levels, NO2 level, and CRF mRNA level in the hypothalamic PVN, and corticosterone concentration in blood. Brain-endothelium, but not hypothalamic PVN samples, from LPS injected rats contained ions for LPS lipids, bound BODIPY-LPS (bLPS), and expressed TLR-4, TLP-2 and CD14 mRNAs. This suggests that (1) LPS does not cross the blood-brain barrier, and (2) brain-endothelial cells contain LPS binding sites, TLR-4, TLR-2 and CD14. Systemic LPS injection increased [14C]sucrose uptake, but did not affect [14C]dextran uptake into the brain. Thus, when injected systemically, LPS binds to its receptor and enter the endothelial cells where it increase BBB permeation in a mass-selective manner and triggers a series of signaling events leading to the development of inflammatory response in the brain.

Original languageEnglish (US)
Pages (from-to)197-207
Number of pages11
JournalToxicology
Volume201
Issue number1-3
DOIs
StatePublished - Sep 1 2004

Fingerprint

Gene expression
Lipopolysaccharides
Rats
Brain
Gene Expression
Endothelial cells
Messenger RNA
Endothelial Cells
Cellular Structures
Corticosterone
Dextrans
Blood-Brain Barrier
Gram-Negative Bacteria
Interleukin-1
Permeation
Cell Wall
Endothelium
Sucrose
Bacteria
Blood

Keywords

  • BBB
  • CORT
  • GC
  • GC receptor
  • GR
  • HPP
  • I
  • IL-1β
  • INT
  • LBP
  • MALDI-TOF
  • blood-brain barrier
  • corticosterone
  • glucocorticoid
  • hypothalamic-pituitary-portal
  • inducible
  • interferon-gamma
  • interleukin-1 beta
  • lipopolysaccharide (LPS) binding protein

Cite this

How does peripheral lipopolysaccharide induce gene expression in the brain of rats? / Singh, Ashok K; Jiang, Yin.

In: Toxicology, Vol. 201, No. 1-3, 01.09.2004, p. 197-207.

Research output: Contribution to journalArticle

@article{ac0d90d00d074371a45d8560191e84bc,
title = "How does peripheral lipopolysaccharide induce gene expression in the brain of rats?",
abstract = "Lipopolysaccharide (LPS), the principal cell-wall component of gram-negative bacteria, is responsible for alterations in the central and peripheral tissues associated with gram-negative infections. However, the mechanism by which peripheral LPS cause central effects is not fully known. This study showed that peripheral LPS sequentially increased IL-1β and iNOS mRNA levels, NO2 level, and CRF mRNA level in the hypothalamic PVN, and corticosterone concentration in blood. Brain-endothelium, but not hypothalamic PVN samples, from LPS injected rats contained ions for LPS lipids, bound BODIPY-LPS (bLPS), and expressed TLR-4, TLP-2 and CD14 mRNAs. This suggests that (1) LPS does not cross the blood-brain barrier, and (2) brain-endothelial cells contain LPS binding sites, TLR-4, TLR-2 and CD14. Systemic LPS injection increased [14C]sucrose uptake, but did not affect [14C]dextran uptake into the brain. Thus, when injected systemically, LPS binds to its receptor and enter the endothelial cells where it increase BBB permeation in a mass-selective manner and triggers a series of signaling events leading to the development of inflammatory response in the brain.",
keywords = "BBB, CORT, GC, GC receptor, GR, HPP, I, IL-1β, INT, LBP, MALDI-TOF, blood-brain barrier, corticosterone, glucocorticoid, hypothalamic-pituitary-portal, inducible, interferon-gamma, interleukin-1 beta, lipopolysaccharide (LPS) binding protein",
author = "Singh, {Ashok K} and Yin Jiang",
year = "2004",
month = "9",
day = "1",
doi = "10.1016/j.tox.2004.04.015",
language = "English (US)",
volume = "201",
pages = "197--207",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "1-3",

}

TY - JOUR

T1 - How does peripheral lipopolysaccharide induce gene expression in the brain of rats?

AU - Singh, Ashok K

AU - Jiang, Yin

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Lipopolysaccharide (LPS), the principal cell-wall component of gram-negative bacteria, is responsible for alterations in the central and peripheral tissues associated with gram-negative infections. However, the mechanism by which peripheral LPS cause central effects is not fully known. This study showed that peripheral LPS sequentially increased IL-1β and iNOS mRNA levels, NO2 level, and CRF mRNA level in the hypothalamic PVN, and corticosterone concentration in blood. Brain-endothelium, but not hypothalamic PVN samples, from LPS injected rats contained ions for LPS lipids, bound BODIPY-LPS (bLPS), and expressed TLR-4, TLP-2 and CD14 mRNAs. This suggests that (1) LPS does not cross the blood-brain barrier, and (2) brain-endothelial cells contain LPS binding sites, TLR-4, TLR-2 and CD14. Systemic LPS injection increased [14C]sucrose uptake, but did not affect [14C]dextran uptake into the brain. Thus, when injected systemically, LPS binds to its receptor and enter the endothelial cells where it increase BBB permeation in a mass-selective manner and triggers a series of signaling events leading to the development of inflammatory response in the brain.

AB - Lipopolysaccharide (LPS), the principal cell-wall component of gram-negative bacteria, is responsible for alterations in the central and peripheral tissues associated with gram-negative infections. However, the mechanism by which peripheral LPS cause central effects is not fully known. This study showed that peripheral LPS sequentially increased IL-1β and iNOS mRNA levels, NO2 level, and CRF mRNA level in the hypothalamic PVN, and corticosterone concentration in blood. Brain-endothelium, but not hypothalamic PVN samples, from LPS injected rats contained ions for LPS lipids, bound BODIPY-LPS (bLPS), and expressed TLR-4, TLP-2 and CD14 mRNAs. This suggests that (1) LPS does not cross the blood-brain barrier, and (2) brain-endothelial cells contain LPS binding sites, TLR-4, TLR-2 and CD14. Systemic LPS injection increased [14C]sucrose uptake, but did not affect [14C]dextran uptake into the brain. Thus, when injected systemically, LPS binds to its receptor and enter the endothelial cells where it increase BBB permeation in a mass-selective manner and triggers a series of signaling events leading to the development of inflammatory response in the brain.

KW - BBB

KW - CORT

KW - GC

KW - GC receptor

KW - GR

KW - HPP

KW - I

KW - IL-1β

KW - INT

KW - LBP

KW - MALDI-TOF

KW - blood-brain barrier

KW - corticosterone

KW - glucocorticoid

KW - hypothalamic-pituitary-portal

KW - inducible

KW - interferon-gamma

KW - interleukin-1 beta

KW - lipopolysaccharide (LPS) binding protein

UR - http://www.scopus.com/inward/record.url?scp=3543091441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543091441&partnerID=8YFLogxK

U2 - 10.1016/j.tox.2004.04.015

DO - 10.1016/j.tox.2004.04.015

M3 - Article

VL - 201

SP - 197

EP - 207

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 1-3

ER -